Clinical Trial Update: A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic Fibrosis and Liver Cirrhosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the safety of Hydronidone capsules in patients with hepatic fibrosis and liver cirrhosis due to chronic hepatitis B is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Fibrosis
• Hepatitis B
• Liver Cirrhosis

Drugs mentioned

• Hydronidone Capsules

Snippet

Sponsor: Beijing Continent Pharmaceutical Co, Ltd. | Conditions: Chronic Hepatitis B With Hepatic Fibrosis | Phase 3 | Status: RECRUITING